Vivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM
18 oct. 2024 08h30 HE
|
Vivos Inc.
Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet therapy. NorthStar Vets - Veterinary Emergency & Trauma Specialty...
Vivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM to Exotics
30 sept. 2024 08h30 HE
|
Vivos Inc.
Richland WA N, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. We recently treated our first exotic animal, a ferret, with encouraging results, seeing a considerable...
Vivos Inc. Provides IDE Submission Status Update – Conversion to Pre-Sub Filing Accepted by the FDA
29 juil. 2024 08h30 HE
|
Vivos Inc.
Richland WA, July 29, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Provides IDE Submission Status Update The FDA has been working diligently to review the extensive amount of...
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
28 juin 2024 10h15 HE
|
Vivos Inc.
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing...
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation
20 déc. 2023 10h08 HE
|
Vivos Inc.
Richland WA, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy...
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics
07 août 2023 09h30 HE
|
Vivos Inc.
Richland WA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that it certified three additional clinics to offer Isopet® Precision Radionuclide Therapy...
Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™
14 sept. 2022 09h30 HE
|
Vivos Inc.
Richland WA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that they filed a patent application on their hydrogel component of IsoPet/RadioGel in the USA...
Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy
16 août 2022 09h30 HE
|
Vivos Inc.
Richland WA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it just certified the New England Equine Practice in Patterson, NY to administer...
Vivos Inc Implements Multiple Patient IsoPet® Therapy Day
21 avr. 2022 09h30 HE
|
Vivos Inc.
Richland WA, April 21, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce a combined IsoPet® therapy schedule into one treatment day, allowing for one production run...
Vivos Inc. Enhances its Intellectual Property Protection
24 févr. 2022 09h30 HE
|
Vivos Inc.
Richland WA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it filed its particle patent in several countries. Our new patent team filed the...